World's Best Scientists 2026 revealed!
VIEW LIST
Parameswaran Hari

D-Index & Metrics

Discipline name D-Index World Ranking Current World Ranking National Ranking Current National Ranking Publications Citations
Medicine 80 16996 15980 8523 7881 802 27194

Parameswaran Hari publications per year

The chart shows the history of publications by Parameswaran Hari between 2000 and 2025, highlighting the no. of papers published in each year and offering an overview of the publication velocity of this scholar. Parameswaran Hari published across 26 years, from 2000 to 2025, averaging 32.7 papers a year. Output peaked at 83 publications in 2021. 41 of the 851 publications appeared in the last two years.

No. of publications
20 40 60 80
Bar chart. Horizontal axis: year, 2000 to 2025. Vertical axis: number of publications, 0 to 83. Peak 83 publications in 2021. 2000: 1 publication 2001: 5 publications 2002: 0 publications 2003: 1 publication 2004: 3 publications 2005: 2 publications 2006: 10 publications 2007: 8 publications 2008: 25 publications 2009: 28 publications 2010: 23 publications 2011: 27 publications 2012: 30 publications 2013: 28 publications 2014: 43 publications 2015: 48 publications 2016: 75 publications 2017: 72 publications 2018: 73 publications 2019: 72 publications 2020: 76 publications 2021: 83 publications 2022: 54 publications 2023: 23 publications 2024: 24 publications 2025: 17 publications
2000 2025

851 publications in total across all disciplines

View publications per year as a table
Parameswaran Hari: publications per year, 2000 to 2025
Year Publications
2000 1
2001 5
2002 0
2003 1
2004 3
2005 2
2006 10
2007 8
2008 25
2009 28
2010 23
2011 27
2012 30
2013 28
2014 43
2015 48
2016 75
2017 72
2018 73
2019 72
2020 76
2021 83
2022 54
2023 23
2024 24
2025 17
Total 851
Download as CSV

Parameswaran Hari publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Parameswaran Hari sits on this spectrum.

No. of scientists
200 400 600 800
Bar chart with 86 bars. Horizontal axis: publications, 101–120 to 1,796+. Vertical axis: number of scientists, 0 to 922. Most scientists, 922, have 341–360 publications. The last bar groups every scientist with 1,796 publications or more. The highlighted bar, 801–820 publications, is where this scientist sits. 101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 610 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101–120 publications 1,796+

This scientist: 802 publications — 87th percentile

87% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

View publications distribution as a table
Number of Medicine scientists by publication count, Research.com 2026 ranking edition. Based on 20,134 ranked scientists.
Publications Scientists This scientist
101–120 5
121–140 26
141–160 73
161–180 155
181–200 230
201–220 363
221–240 487
241–260 545
261–280 722
281–300 768
301–320 834
321–340 895
341–360 922
361–380 838
381–400 861
401–420 918
421–440 806
441–460 771
461–480 751
481–500 713
501–520 617
521–540 610
541–560 537
561–580 504
581–600 509
601–620 396
621–640 386
641–660 371
661–680 340
681–700 336
701–720 307
721–740 259
741–760 230
761–780 228
781–800 217
801–820 204 802
821–840 186
841–860 177
861–880 155
881–900 139
901–920 145
921–940 116
941–960 133
961–980 91
981–1,000 96
1,001–1,020 77
1,021–1,040 70
1,041–1,060 63
1,061–1,080 77
1,081–1,100 49
1,101–1,120 54
1,121–1,140 49
1,141–1,160 51
1,161–1,180 35
1,181–1,200 39
1,201–1,220 26
1,221–1,240 37
1,241–1,260 36
1,261–1,280 27
1,281–1,300 32
1,301–1,320 28
1,321–1,340 17
1,341–1,360 30
1,361–1,380 28
1,381–1,400 17
1,401–1,420 21
1,421–1,440 15
1,441–1,460 12
1,461–1,480 12
1,481–1,500 18
1,501–1,520 14
1,521–1,540 17
1,541–1,560 15
1,561–1,580 6
1,581–1,600 2
1,601–1,620 12
1,621–1,640 11
1,641–1,660 8
1,661–1,680 5
1,681–1,700 5
1,701–1,720 10
1,721–1,740 12
1,741–1,760 14
1,761–1,780 6
1,781–1,795 5
1,796+ 100
Download as CSV

Parameswaran Hari D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Parameswaran Hari sits on this spectrum.

No. of scientists
250 500 750 1,000
Bar chart with 75 bars. Horizontal axis: D-Index, 70–71 to 217+. Vertical axis: number of scientists, 0 to 1,027. Most scientists, 1,027, have 82–83 D-Index. The last bar groups every scientist with 217 D-Index or more. The highlighted bar, 80–81 D-Index, is where this scientist sits. 70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 399 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70–71 D-Index 217+

This scientist: 80 D-Index — 16th percentile

16% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

View D-Index distribution as a table
Number of Medicine scientists by D-index, Research.com 2026 ranking edition. Based on 20,134 ranked scientists.
D-Index Scientists This scientist
70–71 226
72–73 391
74–75 574
76–77 730
78–79 891
80–81 972 80
82–83 1,027
84–85 1,003
86–87 960
88–89 970
90–91 922
92–93 839
94–95 808
96–97 779
98–99 668
100–101 611
102–103 630
104–105 513
106–107 541
108–109 445
110–111 429
112–113 399
114–115 393
116–117 318
118–119 302
120–121 287
122–123 255
124–125 256
126–127 252
128–129 230
130–131 179
132–133 168
134–135 163
136–137 159
138–139 134
140–141 134
142–143 118
144–145 109
146–147 106
148–149 74
150–151 79
152–153 80
154–155 87
156–157 57
158–159 74
160–161 69
162–163 60
164–165 53
166–167 39
168–169 42
170–171 32
172–173 39
174–175 40
176–177 28
178–179 19
180–181 23
182–183 31
184–185 18
186–187 20
188–189 22
190–191 13
192–193 21
194–195 12
196–197 12
198–199 14
200–201 15
202–203 13
204–205 10
206–207 8
208–209 4
210–211 12
212–213 11
214–215 10
216 4
217+ 98
Download as CSV

Overview

Parameswaran Hari is affiliated with the Medical College of Wisconsin in the United States. Their research primarily revolves around the field of Medicine with a focus on Hematology, Oncology, Molecular Biology, Genetics, and Immunology.

The scientist's work covers key topics including:

  • Multiple Myeloma Research and Treatments
  • CAR-T cell therapy research
  • Protein Degradation and Inhibitors
  • Hematopoietic Stem Cell Transplantation
  • Chronic Lymphocytic Leukemia Research
  • Biosimilars and Bioanalytical Methods
  • Cancer Treatment and Pharmacology

Frequent co-authors collaborating with Parameswaran Hari include:

  • Saurabh Chhabra
  • Anita D'Souza
  • Binod Dhakal
  • Mehdi Hamadani
  • Saad Z. Usmani

The scientist has published extensively in several venues. Notable frequent publication venues are:

  • Blood
  • Transplantation and Cellular Therapy
  • Journal of Clinical Oncology
  • Clinical Lymphoma Myeloma & Leukemia
  • Biology of Blood and Marrow Transplantation

Some recent significant papers authored or co-authored by Parameswaran Hari include:

  • Ciltacabtagene autoleucel, a B-cell maturation antigen-directed chimeric antigen receptor T-cell therapy in patients with relapsed or refractory multiple myeloma (CARTITUDE-1): a phase 1b/2 open-label study (2021), The Lancet
  • Current Use of and Trends in Hematopoietic Cell Transplantation in the United States (2020), Biology of Blood and Marrow Transplantation
  • Ciltacabtagene Autoleucel, an Anti-B-cell Maturation Antigen Chimeric Antigen Receptor T-Cell Therapy, for Relapsed/Refractory Multiple Myeloma: CARTITUDE-1 2-Year Follow-Up (2022), Journal of Clinical Oncology
  • Bispecific anti-CD20, anti-CD19 CAR T cells for relapsed B cell malignancies: a phase 1 dose escalation and expansion trial (2020), Nature Medicine
  • Treatment of relapsed and refractory multiple myeloma: recommendations from the International Myeloma Working Group (2021), The Lancet Oncology

Best Publications

  • Lenalidomide after stem-cell transplantation for multiple myeloma

    Philip L. McCarthy;Kouros Owzar;Craig C. Hofmeister;David D. Hurd

  • Ciltacabtagene autoleucel, a B-cell maturation antigen-directed chimeric antigen receptor T-cell therapy in patients with relapsed or refractory multiple myeloma (CARTITUDE-1): a phase 1b/2 open-label study

    Jesus G Berdeja;Deepu Madduri;Saad Z Usmani;Andrzej Jakubowiak

  • Belantamab mafodotin for relapsed or refractory multiple myeloma (DREAMM-2): a two-arm, randomised, open-label, phase 2 study.

    Sagar Lonial;Hans C Lee;Ashraf Z Badros;Suzanne Trudel

  • Current Use and Trends in Hematopoietic Cell Transplantation in the United States

    Anita D'Souza;Anita D'Souza;Stephanie Lee;Stephanie Lee;Xiaochun Zhu;Marcelo Pasquini;Marcelo Pasquini

  • Randomized, multicenter, phase 2 study (EVOLUTION) of combinations of bortezomib, dexamethasone, cyclophosphamide, and lenalidomide in previously untreated multiple myeloma

    Shaji Kumar;Ian Flinn;Paul G. Richardson;Parameswaran Hari

  • Outcomes of patients with multiple myeloma refractory to CD38-targeted monoclonal antibody therapy.

    Ujjawal H. Gandhi;Robert F. Cornell;Arjun Lakshman;Zhubin J. Gahvari

  • Bispecific anti-CD20, anti-CD19 CAR T cells for relapsed B cell malignancies: a phase 1 dose escalation and expansion trial

    Nirav N. Shah;Bryon D. Johnson;Dina Schneider;Fenlu Zhu

  • Autologous haemopoietic stem-cell transplantation followed by allogeneic or autologous haemopoietic stem-cell transplantation in patients with multiple myeloma (BMT CTN 0102): a phase 3 biological assignment trial

    Amrita Krishnan;Marcelo C Pasquini;Brent Logan;Edward A Stadtmauer

  • Long-Term Outcomes Among Older Patients Following Nonmyeloablative Conditioning and Allogeneic Hematopoietic Cell Transplantation for Advanced Hematologic Malignancies

    Mohamed L. Sorror;Brenda M. Sandmaier;Brenda M. Sandmaier;Barry E. Storer;Barry E. Storer;Georg N. Franke

  • Safety and tolerability of ixazomib, an oral proteasome inhibitor, in combination with lenalidomide and dexamethasone in patients with previously untreated multiple myeloma: an open-label phase 1/2 study.

    Shaji K. Kumar;Jesus G. Berdeja;Ruben Niesvizky;Sagar Lonial

  • Natural history of relapsed myeloma, refractory to immunomodulatory drugs and proteasome inhibitors: a multicenter IMWG study

    S. K. Kumar;M. A. Dimopoulos;E. Kastritis;E. Terpos

  • Reduced-Intensity Transplantation for Lymphomas Using Haploidentical Related Donors Versus HLA-Matched Sibling Donors: A Center for International Blood and Marrow Transplant Research Analysis.

    Nilanjan Ghosh;Reem Karmali;Vanderson Rocha;Kwang Woo Ahn

  • PD-1 blockade for relapsed lymphoma post-allogeneic hematopoietic cell transplant: High response rate but frequent GVHD

    Bradley M. Haverkos;Diana Abbott;Mehdi Hamadani;Philippe Armand

  • Hematopoietic Cell Transplantation for Systemic Mature T-Cell Non-Hodgkin Lymphoma

    Sonali M. Smith;Linda J. Burns;Koen W. van Besien;Jennifer LeRademacher

  • Ricolinostat, the First Selective Histone Deacetylase 6 Inhibitor, in Combination with Bortezomib and Dexamethasone for Relapsed or Refractory Multiple Myeloma

    Dan T Vogl;Noopur S Raje;Sundar Jagannath;Paul G. Richardson

  • Autologous Transplantation, Consolidation, and Maintenance Therapy in Multiple Myeloma: Results of the BMT CTN 0702 Trial

    Edward A. Stadtmauer;Marcelo C. Pasquini;Beth Blackwell;Parameswaran Hari

  • Graft-Versus-Host Disease and Graft-Versus-Tumor Effects After Allogeneic Hematopoietic Cell Transplantation

    Rainer Storb;Boglarka Gyurkocza;Boglarka Gyurkocza;Barry E. Storer;Barry E. Storer;Mohamed L. Sorror;Mohamed L. Sorror

  • Three prophylaxis regimens (tacrolimus, mycophenolate mofetil, and cyclophosphamide; tacrolimus, methotrexate, and bortezomib; or tacrolimus, methotrexate, and maraviroc) versus tacrolimus and methotrexate for prevention of graft-versus-host disease with haemopoietic cell transplantation with reduced-intensity conditioning: a randomised phase 2 trial with a non-randomised contemporaneous control group (BMT CTN 1203)

    Javier Bolaños-Meade;Ran Reshef;Raphael Fraser;Mingwei Fei

  • Pembrolizumab plus pomalidomide and dexamethasone for patients with relapsed or refractory multiple myeloma (KEYNOTE-183): a randomised, open-label, phase 3 trial.

    Maria-Victoria Mateos;Hilary Blacklock;Fredrik Schjesvold;Albert Oriol

  • Natural History of Relapsed Myeloma, Refractory to Immunomodulatory Drugs and Proteasome Inhibitors: A Multicenter IMWG Study

    Shaji Kumar;Meletios A Dimopoulos;Efstathios Kastritis;Evangelos Terpos

Frequent Co-Authors

Marcelo C. Pasquini
Marcelo C. Pasquini Medical College of Wisconsin
Mei-Jie Zhang
Mei-Jie Zhang Medical College of Wisconsin
Shaji Kumar
Shaji Kumar Mayo Clinic
Hillard M. Lazarus
Hillard M. Lazarus Case Western Reserve University
Saad Z. Usmani
Saad Z. Usmani Memorial Sloan Kettering Cancer Center
David G. Maloney
David G. Maloney Fred Hutchinson Cancer Research Center
William R. Drobyski
William R. Drobyski Medical College of Wisconsin
Sergio Giralt
Sergio Giralt Memorial Sloan Kettering Cancer Center
Sagar Lonial
Sagar Lonial Emory University
Brenda M. Sandmaier
Brenda M. Sandmaier Fred Hutchinson Cancer Research Center

External Links

Personal website of Parameswaran Hari

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you're interested in medical careers but want flexible study options, several accredited online degrees can help you launch or advance your healthcare journey. For Registered Nurses seeking to specialize, rn to fnp bridge programs offer a direct route from RN to Family Nurse Practitioner, supporting career growth without requiring a traditional campus setting.

For those passionate about diet, health, and wellness, earning a nutritionist online degree is a versatile way to build expert knowledge in nutrition science and qualify for rewarding roles in healthcare or the food industry.

If healthcare management is your goal, it's vital to know how to evaluate healthcare administration degree programs. Look for programs with CAHME accreditation to ensure high educational standards and optimal career outcomes.

Finally, RNs wishing to advance without on-site clinicals can consider online rn to bsn programs without clinicals. These programs offer flexible scheduling for licensed professionals eager to boost their credentials while balancing work or family commitments.

Best Scientists Citing Parameswaran Hari

Shaji Kumar

Shaji Kumar

Mayo Clinic

Publications: 164

Sergio Giralt

Sergio Giralt

Memorial Sloan Kettering Cancer Center

Publications: 151

Paul G. Richardson

Paul G. Richardson

Harvard University

Publications: 133

Morie A. Gertz

Morie A. Gertz

Mayo Clinic

Publications: 115

Meletios A. Dimopoulos

Meletios A. Dimopoulos

National and Kapodistrian University of Athens

Publications: 113

Miguel-Angel Perales

Miguel-Angel Perales

Memorial Sloan Kettering Cancer Center

Publications: 100

Kenneth C. Anderson

Kenneth C. Anderson

Harvard University

Publications: 98

Angela Dispenzieri

Angela Dispenzieri

Mayo Clinic

Publications: 95

S. Vincent Rajkumar

S. Vincent Rajkumar

Mayo Clinic

Publications: 88

Nicolaus Kröger

Nicolaus Kröger

Universität Hamburg

Publications: 87

Sagar Lonial

Sagar Lonial

Emory University

Publications: 84

Francis K. Buadi

Francis K. Buadi

Mayo Clinic

Publications: 81

Mario Boccadoro

Mario Boccadoro

University of Turin

Publications: 81

Antonio Palumbo

Antonio Palumbo

University of Turin

Publications: 76

Hermann Einsele

Hermann Einsele

University of Würzburg

Publications: 71

Hartmut Goldschmidt

Hartmut Goldschmidt

University Hospital Heidelberg

Publications: 71

Trending Scientists

Roger T. Howe

Roger T. Howe

Stanford University

Paulette Spencer

Paulette Spencer

University of Kansas

Pascal Jacques

Pascal Jacques

Université Catholique de Louvain

Göran Stemme

Göran Stemme

Royal Institute of Technology

Martin A. Lindquist

Martin A. Lindquist

Johns Hopkins University

Ed Manser

Ed Manser

Agency for Science, Technology and Research

Soma Das

Soma Das

University of Chicago

Rolf H. Möhring

Rolf H. Möhring

Technical University of Berlin

Giuseppe Riccardi

Giuseppe Riccardi

University of Trento

David E. Thurston

David E. Thurston

King's College London

Tetsuhiko Kobayashi

Tetsuhiko Kobayashi

National Institute of Advanced Industrial Science and Technology

Daniel L. Comins

Daniel L. Comins

North Carolina State University

Christine M. Albert

Christine M. Albert

Cedars-Sinai Medical Center

Laura C. Rodrigues

Laura C. Rodrigues

London School of Hygiene & Tropical Medicine

Ian P. Woiwod

Ian P. Woiwod

Rothamsted Research

Roger P. Harris

Roger P. Harris

Plymouth Marine Laboratory

Related Medicine Rankings & Guides

2027 Most Affordable Master’s Degrees in Healthcare Administration

2027 Most Affordable Master’s Degrees in Healthcare Administration
2027 Best Nurse Practitioner Programs in Florida – Accredited Schools Online & Campus

2027 Best Nurse Practitioner Programs in Florida – Accredited Schools Online & Campus
2027 Best Online Nursing Programs in Florida – Accredited RN to BSN Programs

2027 Best Online Nursing Programs in Florida – Accredited RN to BSN Programs
2027 Best Nursing Schools in Utah – Accredited ADN, BSN & MSN Programs

2027 Best Nursing Schools in Utah – Accredited ADN, BSN & MSN Programs
2027 How Fast Can I Finish an RN to BSN

2027 How Fast Can I Finish an RN to BSN
2027 Best Online CAHME-Accredited MHA Programs

2027 Best Online CAHME-Accredited MHA Programs
2027 Most Affordable Online Health Information Management Degree Programs

2027 Most Affordable Online Health Information Management Degree Programs
2027 Easiest MPH Online Programs to Get Into

2027 Easiest MPH Online Programs to Get Into
2027 Best Shortest Online DNP Programs

2027 Best Shortest Online DNP Programs
2027 Best Nurse Practitioner Programs in New Jersey – Accredited Schools Online & Campus

2027 Best Nurse Practitioner Programs in New Jersey – Accredited Schools Online & Campus
2027 Best Pharmacy Schools & Pharmacist Programs Requirements in Florida: Online & Campus

2027 Best Pharmacy Schools & Pharmacist Programs Requirements in Florida: Online & Campus
2027 Best Occupational Therapy Programs

2027 Best Occupational Therapy Programs
2027 Best Online Master’s in Clinical Research Programs

2027 Best Online Master’s in Clinical Research Programs
2027 Fastest Online MSN in Forensic Nursing Programs

2027 Fastest Online MSN in Forensic Nursing Programs
2027 Cheapest Online Nursing Informatics Degree Programs

2027 Cheapest Online Nursing Informatics Degree Programs
2027 Best Online BSN to FNP Programs

2027 Best Online BSN to FNP Programs
2027 Best Online Dual FNP/PMHNP Degree Programs

2027 Best Online Dual FNP/PMHNP Degree Programs
2027 Is Grand Canyon University School of Nursing Worth It?

2027 Is Grand Canyon University School of Nursing Worth It?
2027 Most Affordable Master’s in Health Science Degrees

2027 Most Affordable Master’s in Health Science Degrees
2027 Best Online Associate in Physical Therapy Assistant Programs

2027 Best Online Associate in Physical Therapy Assistant Programs
2027 Most Affordable Online Medical Billing and Coding Courses

2027 Most Affordable Online Medical Billing and Coding Courses

Recently Published Articles

2027 Intelligence Degree Coursework Explained: What Classes Can You Expect to Take?

2027 Intelligence Degree Coursework Explained: What Classes Can You Expect to Take?
2027 AI Degree Programs With the Best Career Outcomes

2027 AI Degree Programs With the Best Career Outcomes
2027 Cheapest and Shortest Online Analytics Degree Programs That Pay Well: Cost, Duration, and Salary Outlook

2027 Cheapest and Shortest Online Analytics Degree Programs That Pay Well: Cost, Duration, and Salary Outlook
2027 AI, Automation, and the Future of Political Communication Degree Careers

2027 AI, Automation, and the Future of Political Communication Degree Careers
2027 Hardest and Easiest Courses in a Biochemistry Degree Program

2027 Hardest and Easiest Courses in a Biochemistry Degree Program
2027 Most Affordable Online Master's Degrees in Engineering Management

2027 Most Affordable Online Master's Degrees in Engineering Management
2027 Different Types of Addiction Psychology Bachelor's Degrees: Specializations, Careers, and Salaries

2027 Different Types of Addiction Psychology Bachelor's Degrees: Specializations, Careers, and Salaries
2027 Counseling Psychology Careers: Guide to Career Paths, Options & Salary

2027 Counseling Psychology Careers: Guide to Career Paths, Options & Salary
2027 Different Types of Criminal Justice Master's Degrees: Specializations, Careers, and Salaries

2027 Different Types of Criminal Justice Master's Degrees: Specializations, Careers, and Salaries
2027 Best Medical Transcription Courses Online

2027 Best Medical Transcription Courses Online
2027 Are Too Many Students Choosing Respiratory Care Therapy? Oversaturation, Competition, and Hiring Reality

2027 Are Too Many Students Choosing Respiratory Care Therapy? Oversaturation, Competition, and Hiring Reality
2027 Nutrition Specializations With the Strongest Salary Growth

2027 Nutrition Specializations With the Strongest Salary Growth
2027 Am I Eligible for a Forensic Science Degree Master's Program? Admission Checklist & Options

2027 Am I Eligible for a Forensic Science Degree Master's Program? Admission Checklist & Options
2027 How to Become a Licensed Therapist (LPC) in Nashville, TN

2027 How to Become a Licensed Therapist (LPC) in Nashville, TN
2027 Can You Get Into a Nonprofit Management Program with a Low GPA? Admission Chances & Workarounds

2027 Can You Get Into a Nonprofit Management Program with a Low GPA? Admission Chances & Workarounds
2027 Best Online General Psychology Doctorate Specializations for Career Growth

2027 Best Online General Psychology Doctorate Specializations for Career Growth
2027 Industries Hiring Graduates With an Educational Psychology Degree

2027 Industries Hiring Graduates With an Educational Psychology Degree
2027 Online Social Work Bachelor's Degree Programs With Accelerated Courses

2027 Online Social Work Bachelor's Degree Programs With Accelerated Courses
2027 How to Become a Marketing Analyst

2027 How to Become a Marketing Analyst
2027 Cheapest and Shortest Online Educational Policy Degree Programs That Pay Well: Cost, Duration, and Salary Outlook

2027 Cheapest and Shortest Online Educational Policy Degree Programs That Pay Well: Cost, Duration, and Salary Outlook
2027 Is Cybersecurity a Hard Major? What Students Should Know

2027 Is Cybersecurity a Hard Major? What Students Should Know